Pradyun Chakravarty 
Dealstreet

Legacy Law Offices acts on Sheel Biotech IPO

The IPO comprised a fresh offer of 54,00,000 shares, aggregating to ₹34.1 crore.

Bar & Bench

Sheel Biotech Limited has made an initial public offering comprising a fresh offer of 54,00,000 shares, aggregating to ₹34.1 crore.

Legacy Law Offices advised Sheel Biotech on this IPO.

The transaction was led by Pradyun Chakravarty (Associate Partner), with support from Nandish Munjal (Senior Associate) and Sayed Anas (Associate).

Sheel Biotech

Sheel Biotech is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. The Company manufactures and maintains greenhouses, offers services to farmers, and provides training through Farmer-Producer Organisations (FPOs). Additionally, the Company also delivers green landscaping services to both the government and private sectors.

The IPO received a robust response and was oversubscribed by 15.97 times.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Down's Syndrome patients entitled to guardianship under National Trust Act: Kerala HC

Mere copy-paste of law by ED not sufficient: Karnataka HC quashes property attachment in MUDA case

Amitabh Jhunjhunwala sent to CBI custody for 5 days in fraud case

Indian arbitration story positive, but the excessive workload of the court system remains a bottleneck: Senior Advocate Gaurav Pachnanda

The pathology of ‘consider' jurisprudence

SCROLL FOR NEXT